Home |  News |  Events |  Publications |  Contact 
Corporate Investor LifeScience Diagnostics Commercial Technology Career
Welcome to the Gradipore Website

Gradipore is a global biotechnology company that researches, develops, manufactures and markets separation technologies for the life sciences market, and blood clotting tests for genetic disorders for the health industry.

Gradipore's technologies and products enable research, development and production of biological products from plants to humans and promote the detection of disease, and the manufacturing of pharmaceuticals.

Gradipore's core separation technology platform, GradiflowTM, is a unique membrane-based process for large-scale biological separations and has a wide range of applications in research, scientific and commercial environments including blood purification and biological drug manufacturing. Unlike other large-scale blood purification technologies, Gradiflow can purify proteins and remove viral and bacterial pathogens simultaneously.

 Featured News more  

Appointment of Jeremy Davis as Chairman
GRADIPORE APPOINTS JEREMY DAVIS CHAIRMAN OF THE BOARD --Seasoned Business Executive Brings Over 30 years of Management Experience-- SYDNEY (September 23, 2002) Gradipore, a global biotechnolog ...
[ Find out more.]

 Latest News more  

 2002 Appendix 4B Report
 Financial Results 2002
 Cangene and Gradipore sign Licensing Agreement

Privacy Statement | Contact Us | Terms of Use | | Terms of Use |
2002 Gradipore Limited All rights reserved.